Non-adjuvanted trivalent split influenza vaccine (control)

influenza vaccine, split, trivalent, non-adjuvanted · Novartis Vaccines

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Non-adjuvanted trivalent split influenza vaccine (control), covering 2014-05-06 to 2014-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age [Phase 3]

See pricing